Care for what people don’t talk about.
From £145.00
Wegovy is a once-weekly weight loss injection containing semaglutide, a medicine that mimics the natural GLP-1 hormone. It works on areas of the brain that regulate appetite, helping you feel fuller for longer, reduce hunger and manage food cravings.
Used alongside a reduced-calorie diet and increased physical activity, Wegovy can support weight loss and long-term weight management in eligible adults. Treatment starts at a low dose and increases gradually to help minimise side effects. At PillSuite, a qualified UK prescriber will review your medical history and assess whether Wegovy is suitable for you before treatment is prescribed.
Discreet UK delivery, dispatched once your consultation is approved.
UK licensed medication
UK-wide delivery
Discreet packaging
Free expert advice & supportWegovy treatment starts at 0.25 mg once weekly, with the dose gradually increased to help your body adjust and reduce gastrointestinal side effects.
Doses are typically increased every four weeks, but your prescriber may delay an increase or recommend remaining on a lower dose if clinically appropriate. Your treatment plan will be guided by your progress, response and how well you tolerate the medication.
| Strength | How it's taken | Price |
|---|---|---|
| 0.25 mg | Once weekly | £145.00 |
| 0.5 mg | Once weekly | £160.00 |
| 1 mg | Once weekly | £179.00 |
| 1.7 mg | Once weekly | £190.00 |
| 2.4 mg | Once weekly | £210.00 |
| 7.2 mg | Once weekly | £270.00 |
Standard Wegovy FlexTouch pens contain four weekly doses, providing a 4-week supply. The dedicated 7.2 mg pen delivers one weekly dose per injection.
Your prescriber will review your response and tolerability. Dose increases may be delayed or adjusted where clinically appropriate.
This page is written for general information. It does not replace advice from your own prescriber or GP, and it is not a recommendation that this medicine is right for you.
Wegovy is a prescription-only weight loss medication containing semaglutide, a GLP-1 receptor agonist. It is used alongside a reduced-calorie diet and increased physical activity to help eligible adults lose weight and maintain weight loss.
Wegovy is administered as a once-weekly injection, with treatment prescribed following a clinical assessment.
Wegovy contains semaglutide, which mimics the action of GLP-1, a natural hormone involved in regulating appetite.
It works on areas of the brain that control hunger and fullness, helping you feel satisfied for longer, reduce food cravings and eat less. When combined with a reduced-calorie diet and increased physical activity, this can support sustained weight loss.
Wegovy is injected once weekly under the skin of your abdomen, thigh or upper arm. You can change injection sites each week and should avoid injecting into exactly the same spot each time.
Treatment usually starts at 0.25 mg, increasing to 0.5 mg, 1 mg, 1.7 mg and then 2.4 mg at four-week intervals, depending on how well you tolerate the medication. Your prescriber may adjust or delay dose increases where appropriate.
Wegovy can be taken at any time of day, with or without food. If you miss a dose, take it within five days of your scheduled injection. If more than five days have passed, skip it and resume your usual schedule. Never double your dose.
In the STEP 1 clinical trial, participants taking Wegovy (semaglutide 2.4 mg) lost an average of 14.9% of their starting body weight over 68 weeks, compared with 2.4% in those receiving a placebo. Both groups followed a reduced-calorie diet and increased physical activity.
Individual results vary depending on treatment response and lifestyle factors. Weight loss is not guaranteed, and Wegovy should be used alongside sustainable lifestyle changes.
Like all medicines, Wegovy (semaglutide) can cause side effects, although not everyone experiences them. These are often more noticeable when starting treatment or increasing the dose.
Common side effects include:
How can I manage side effects?
Eating smaller meals, avoiding rich or fatty foods and staying hydrated may help. If side effects persist or become difficult to manage, speak to your prescriber, as your dose may need reviewing.
When should I seek medical help?
Seek urgent medical assessment for severe, persistent abdominal pain, particularly if it spreads to your back, or sudden loss of vision. Seek emergency help for breathing difficulties or swelling of the face, lips or throat.
Persistent vomiting or diarrhoea can cause dehydration. Contact a healthcare professional promptly if you cannot keep fluids down.
For a complete list of side effects and precautions, read the patient information leaflet supplied with your medication.
Wegovy may be suitable for adults who meet the following BMI criteria:
Lower BMI thresholds may apply to people from certain ethnic backgrounds due to increased health risks at lower BMI levels.
Suitability also depends on your medical history, current medications and individual circumstances. A qualified prescriber will assess whether Wegovy is appropriate and safe for you before prescribing.
Wegovy is not suitable for everyone. You should not use Wegovy if you:
Speak to your prescriber before treatment if you have:
Wegovy should be stopped at least two months before a planned pregnancy. Your prescriber will review your medical history and current medications to assess whether treatment is safe and appropriate.
Wegovy is designed for long-term weight management, rather than short-term weight loss. There is no fixed maximum treatment duration, provided the medication remains suitable, effective and well tolerated.
Your prescriber will regularly review your progress, side effects and overall health to determine whether treatment should continue.
Stopping Wegovy may lead to weight regain, so maintaining healthy eating habits and regular physical activity remains important.
Always read the information supplied with your medicine.
GETTING STARTED
Your Wegovy journey begins with a personalised assessment to make sure treatment is right for you.
AS TREATMENT CONTINUES
Your Wegovy dose is gradually adjusted to help you find a treatment plan that works for you.
LONGER-TERM TREATMENT
Long-term weight management is about maintaining progress and building healthy habits that last.
Eligibility check
Weight loss treatment is typically suitable for a BMI of 30+, or 27+ with a weight-related condition.
Use the calculator to see if you may be eligible.
No obligation · Takes about 3 minutes
You can edit the value
You can edit the value
Your BMI
Enter your height and weight to see an estimate.
BMI categories
What this means: BMI is one of several factors used to assess whether weight loss treatment may be suitable for you. Treatment is subject to a clinical assessment.
This calculator provides an estimate only. BMI does not account for muscle mass, body composition or ethnicity. Eligibility is confirmed by a clinician during your consultation. Treatment is not suitable in pregnancy, while breastfeeding, or when trying to conceive.
Why go with PillSuite
Your treatment is assessed by a qualified UK prescriber who reviews your medical history and suitability before making a prescribing decision.
We supply genuine, UK-licensed medicines sourced through regulated pharmaceutical suppliers, with appropriate checks to ensure quality and safety.
Our support doesn't stop when your treatment arrives. We're here to answer questions, review your progress and help you manage your treatment with confidence.
Your treatment recommendations are based on your medical history, health needs and individual circumstances, helping your prescriber make an informed decision about your care.
Find out whether Wegovy could be suitable for you with a confidential online consultation and assessment by a qualified UK prescriber.
Start consultation
